Missouri HB3499 modifies pharmacist duties to include medication therapy services for influenza, streptococcus, and COVID-19.

Missouri HB3499 modifies the duties of pharmacists by allowing those with a certificate of medication therapeutic plan authority to provide medication therapy services for influenza, group A streptococcus, and COVID-19. The bill also mandates that the state board of registration for the healing arts and the board of pharmacy jointly create rules for these services. These rules must be established within six months of the bill's effective date. The bill further defines "medical device" and outlines the conditions under which pharmacists may prescribe such devices.

Missouri HB3499 modifies pharmacist duties to include medication therapy services for influenza, streptococcus, and COVID-19.

Missouri HB3499 modifies the duties of pharmacists by allowing those with a certificate of medication therapeutic plan authority to provide medication therapy services for influenza, group A streptococcus, and COVID-19. The bill also mandates that the state board of registration for the healing arts and the board of pharmacy jointly create rules for these services. These rules must be established within six months of the bill's effective date. The bill further defines "medical device" and outlines the conditions under which pharmacists may prescribe such devices.